Katsarelias, D.; Eriksson, H.; Mikiver, R.; Krakowski, I.; Nilsson, J.A.; Ny, L.; Olofsson Bagge, R.
Reply to Comment on Katsarelias, D., et al. “The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study.” Cancers 2020, 12, 3228. Cancers 2021, 13, 92.
https://doi.org/10.3390/cancers13010092
AMA Style
Katsarelias D, Eriksson H, Mikiver R, Krakowski I, Nilsson JA, Ny L, Olofsson Bagge R.
Reply to Comment on Katsarelias, D., et al. “The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study.” Cancers 2020, 12, 3228. Cancers. 2021; 13(1):92.
https://doi.org/10.3390/cancers13010092
Chicago/Turabian Style
Katsarelias, Dimitrios, Hanna Eriksson, Rasmus Mikiver, Isabelle Krakowski, Jonas A. Nilsson, Lars Ny, and Roger Olofsson Bagge.
2021. "Reply to Comment on Katsarelias, D., et al. “The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study.” Cancers 2020, 12, 3228" Cancers 13, no. 1: 92.
https://doi.org/10.3390/cancers13010092
APA Style
Katsarelias, D., Eriksson, H., Mikiver, R., Krakowski, I., Nilsson, J. A., Ny, L., & Olofsson Bagge, R.
(2021). Reply to Comment on Katsarelias, D., et al. “The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma—A Nation-Wide Swedish Population-Based Retrospective Register Study.” Cancers 2020, 12, 3228. Cancers, 13(1), 92.
https://doi.org/10.3390/cancers13010092
